SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: AgFinder who wrote (2605)5/3/1999 10:23:00 PM
From: Epicenter  Read Replies (1) of 10280
 
Dear SEPR board:

As many of you know, I am long on SEPR, long term, so I'll add to my position either now or when the "bottom" is apparent--not clear where that is though, yet.

Last night, I ended up staying overnight at Englewood Hospital, NJ because of my son's acute asthmatic attack. He got tons of Albuterol via nebulizer but NO ONE at the hospital ever heard of the imminent arrival of Xoponex, to my amazement! This included 4 respiratory therapists, half a dozen nurses, and maybe another half dozen ER workers including 2 physicians. I am not sure this hospital is typical but certainly a little discouraging considering the fact that I was witnessing first hand the side effects of Albuterol (Yes, I am aware that Xoponex is not approved for children yet)

SEPR has a great story but maybe the stock got too far ahead of itself. I hate to admit it but it may be a while before we see a major sustainable upswing. In the mean time, I'll add to my position.

Any thoughts?

Epicenter2
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext